CC(C)(C)n1nc2c(c1NC(=O)c1cc(Cl)ccc1[N+](=O)[O-])CS(=O)(=O)C2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?